Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025
Tactile Medical (Nasdaq: TCMD) announced it will release third quarter fiscal 2025 financial results after market close on Monday, November 3, 2025. Management will host a conference call with Q&A on November 3, 2025 at 5:00 p.m. ET.
Investors can join by phone at 877-407-3088 (international 201-389-0927) using access code 13755883, or listen via live webcast at investors.tactilemedical.com. A replay will be available for two weeks at 877-660-6853 (international 201-612-7415), access code 13755883. The webcast will be archived on the investor site.
About the company: Tactile Medical develops at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease to expand access and improve patient quality of life.
Tactile Medical (Nasdaq: TCMD) ha annunciato che posterà i risultati finanziari del terzo trimestre fiscale 2025 dopo la chiusura del mercato di lunedì 3 novembre 2025. La direzione terrà una conference call con domande e risposte il 3 novembre 2025 alle 17:00 ora ET.
Gli investitori possono partecipare telefonicamente al numero 877-407-3088 (internazionale 201-389-0927) utilizzando il codice di accesso 13755883, oppure ascoltare tramite webcast in diretta all'indirizzo investors.tactilemedical.com. Una registrazione sarà disponibile per due settimane al numero 877-660-6853 (internazionale 201-612-7415), codice di accesso 13755883. Il webcast sarà archiviato sul sito degli investitori.
About the company: Tactile Medical sviluppa terapie domiciliari per condizioni croniche tra cui linfedema, lipedema, insufficienza venosa cronica e malattia polmonare cronica per ampliare l'accesso e migliorare la qualità della vita dei pazienti.
Tactile Medical (Nasdaq: TCMD) anunció que publicará los resultados financieros del tercer trimestre fiscal de 2025 después del cierre del mercado el lunes 3 de noviembre de 2025. La dirección celebrará una conferencia telefónica con preguntas y respuestas el 3 de noviembre de 2025 a las 5:00 p.m. ET.
Los inversores pueden unirse por teléfono al 877-407-3088 (internacional 201-389-0927) usando el código de acceso 13755883, o escuchar mediante webcast en vivo en investors.tactilemedical.com. Habrá una reproducción disponible durante dos semanas en el 877-660-6853 (internacional 201-612-7415), código de acceso 13755883. El webcast se archivará en el sitio de inversores.
Acerca de la empresa: Tactile Medical desarrolla terapias en casa para condiciones crónicas como linfedema, lipedema, insuficiencia venosa crónica y enfermedad pulmonar crónica para ampliar el acceso y mejorar la calidad de vida de los pacientes.
Tactile Medical (나스닥: TCMD) 은 2025 회계연도 제3분기 재무실적을 2025년 11월 3일 월요일 장 마감 후 발표할 것이라고 발표했습니다. 경영진은 2025년 11월 3일 오후 5:00(동부표준시)에 Q&A를 포함한 컨퍼런스 콜을 주최합니다.
투자자들은 전화로 877-407-3088 (국제 송신 201-389-0927) 에 접속코드 13755883 를 사용하여 참여하거나 investors.tactilemedical.com의 라이브 웨비캐스트를 통해 청취할 수 있습니다. 2주간 재생은 877-660-6853 (국제 201-612-7415), 접속코드 13755883에서 이용 가능합니다. 웨비캐스트는 투자자 사이트에 보관됩니다.
회사에 대하여: Tactile Medical 은 림프부종, 지방부종, 만성 정맥 기능부전, 만성 폐질환 등 만성 질환에 대한 가정용 치료를 개발하여 접근성을 확대하고 환자의 삶의 질을 향상시킵니다.
Tactile Medical (Nasdaq : TCMD) a annoncé qu'il publiera les résultats financiers du troisième trimestre fiscal 2025 après la clôture du marché le lundi 3 novembre 2025. La direction organisera une conférence téléphonique avec questions/réponses le 3 novembre 2025 à 17 h (HE).
Les investisseurs peuvent joindre par téléphone au 877-407-3088 (international 201-389-0927) en utilisant le code d'accès 13755883, ou écouter via webcast en direct sur investors.tactilemedical.com. Une rediffusion sera disponible pendant deux semaines au 877-660-6853 (international 201-612-7415), code d'accès 13755883. Le webcast sera archivé sur le site des investisseurs.
À propos de l'entreprise : Tactile Medical développe des thérapies à domicile pour les affections chroniques telles que le lymphœdème, le lipœdème, l'insuffisance veineuse chronique et les maladies pulmonaires chroniques afin d'accroître l'accès et d'améliorer la qualité de vie des patients.
Tactile Medical (Nasdaq: TCMD) gab bekannt, dass es die Ergebnisse des dritten Quartals 2025 nach Börsenschluss am Montag, dem 3. November 2025 veröffentlichen wird. Das Management wird am 3. November 2025 um 17:00 Uhr EST eine Konferenzschaltung mit Q&A abhalten.
Investoren können sich telefonisch unter 877-407-3088 (international 201-389-0927) mit dem Zugangs-Code 13755883 verbinden oder den Live-Webcast unter investors.tactilemedical.com anhören. Eine Aufzeichnung wird für zwei Wochen verfügbar sein unter 877-660-6853 (international 201-612-7415), Zugangs-Code 13755883. Der Webcast wird auf der Investorenseite archiviert.
Über das Unternehmen: Tactile Medical entwickelt Therapien für zu Hause bei chronischen Erkrankungen wie Lymphödem, Lipödem, chronischer venöser Insuffizienz und chronischer Lungenerkrankung, um den Zugang zu erweitern und die Lebensqualität der Patienten zu verbessern.
Tactile Medical (ناسداك: TCMD) أعلنت أنها ستصدر نتائجها المالية للربع الثالث من السنة المالية 2025 بعد إغلاق السوق يوم الإثنين 3 نوفمبر 2025. سيعقد الإدارة مكالمة مؤتمرات مع أسئلة وأجوبة في 3 نوفمبر 2025 الساعة 5:00 مساءً بالتوقيت الشرقي.
يمكن للمستثمرين الانضمام عبر الهاتف على الرقم 877-407-3088 (الدولي 201-389-0927) باستخدام رمز الدخول 13755883، أو الاستماع عبر البث المباشر على موقع investors.tactilemedical.com. سيكون البث المتكرر متاحاً لمدة أسبوعين على الرقم 877-660-6853 (الدولي 201-612-7415)، رمز الدخول 13755883. سيُخزن البث على موقع المستثمرين.
عن الشركة: تطور Tactile Medical علاجات منزلية للحالات المزمنة بما في ذلك وذمة لمفية، وذمة دهنية، وفشل صمامي وريدي مزمن، ومرض رئة مزمن لتوسيع الوصول وتحسين جودة حياة المرضى.
Tactile Medical (纳斯达克代码：TCMD) 宣布将于2025财年第三季度财报在市场收盘后发布，时间为2025年11月3日，星期一。管理层将于美国东部时间2025年11月3日 17:00举行电话会议并进行问答。
投资者可通过电话加入，拨打877-407-3088（国际区号 201-389-0927）并使用访问代码13755883，或通过现场网络直播收听，地址为investors.tactilemedical.com。两周内将提供回放，电话为877-660-6853（国际区号 201-612-7415），访问代码13755883。网络直播将在投资者网站上存档。
关于公司： Tactile Medical 开发用于慢性疾病的家庭治疗方案，包括淋巴水肿、脂肪水肿、慢性静脉功能不全和慢性肺病，以扩大可及性并改善患者生活质量。
- None.
- None.
MINNEAPOLIS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2025 financial results will be released after the market closes on Monday, November 3, 2025.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 3, 2025, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13755883. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13755883. The webcast will be archived at investors.tactilemedical.com.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
When will Tactile Medical (TCMD) release Q3 fiscal 2025 financial results?
What time is the TCMD earnings conference call on November 3, 2025?
How can investors join the Tactile Medical (TCMD) November 3, 2025 call?
Will there be a replay of the TCMD Q3 2025 conference call and how long will it be available?
Where will Tactile Medical archive the November 3, 2025 webcast?
What does Tactile Medical (TCMD) specialize in and why should investors care?
